Loading...

Antonino Catanzaro

TitleRecall Hcomp
InstitutionUniversity of California San Diego
DepartmentMedicine
Address9500 Gilman Drive #0643
La Jolla CA 92093
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Identifying individuals at risk of progression to active tuberculosis
    NIH/NIAID R01AI137681Feb 22, 2018 - Jan 31, 2023
    Role: Principal Investigator
    An Integrated Tabletop Platform for Rapid Detection of XDR-TB in Clinical Samples
    NIH/NIAID R01AI111435Jul 1, 2014 - Jun 30, 2019
    Role: Principal Investigator
    Cough collection as a replacement for sputum samples for diagnosing Tuberculosis
    NIH/NIAID R43AI102418Jun 15, 2012 - May 31, 2014
    Role: Principal Investigator
    Rapid Tests for Drug Resistance to Detect Extensively Drug-Resistant Tuberculosis
    NIH/NIAID U01AI082229Sep 27, 2009 - Aug 31, 2014
    Role: Principal Investigator
    National Tuberculosis Curriculum Consortium (NTCC)
    NIH/NHLBI N01HR36157-7-0-1Sep 30, 2003 - Apr 30, 2010
    Role: Principal Investigator
    Clinical Suspicion of TB: A Technology Assessment Tool
    NIH/NIAID R01AI053731Aug 1, 2003 - Jan 31, 2009
    Role: Principal Investigator
    INHALED CYTOKINES FOR MYCOBACTERIAL LUNG DISEASE
    NIH/NIA R03AG017307Aug 1, 1999 - Jul 31, 2001
    Role: Principal Investigator
    TUBERCULOSIS
    NIH/NHLBI K07HL003065Sep 30, 1993 - Aug 31, 2001
    Role: Principal Investigator
    PATHOGENESIS OF OPPORTUNISTIC INFECTION DUE TO MAC
    NIH/NIAID R01AI033827Sep 30, 1992 - May 31, 1997
    Role: Principal Investigator
    General Clinical Research Center
    NIH/NCRR M01RR000827Mar 1, 1974 - Nov 30, 2010
    Role: Co-Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Groessl EJ, Ganiats TG, Hillery N, Trollip A, Jackson RL, Catanzaro DG, Rodwell TC, Garfein RS, Rodrigues C, Crudu V, Victor TC, Catanzaro A. Cost analysis of rapid diagnostics for drug-resistant tuberculosis. BMC Infect Dis. 2018 03 02; 18(1):102. PMID: 29499645.
      View in: PubMed
    2. Thompson GR, Blair JE, Wang S, Bercovitch R, Bolaris M, Van Den Akker D, Lopez R, Heidari A, Catanzaro A, Cadena J, Chin-Hong P, Spellberg B, Johnson R. Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis. Clin Infect Dis. 2017 Jul 15; 65(2):338-341. PMID: 28419259.
      View in: PubMed
    3. Catanzaro DG, Trollip AP, Seifert M, Georghiou SB, Garfein RS, Rodwell TC, Catanzaro A, Eisenach KD. Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for Mycobacterium tuberculosis. Eur Respir J. 2017 Apr; 49(4). PMID: 28381434.
      View in: PubMed
    4. Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, Johnson RH, Kusne S, Lisse J, MacDonald JD, Meyerson SL, Raksin PB, Siever J, Stevens DA, Sunenshine R, Theodore N. Executive Summary: 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis. Clin Infect Dis. 2016 Sep 15; 63(6):717-22. PMID: 27559032.
      View in: PubMed
    5. Georghiou SB, Seifert M, Lin SY, Catanzaro D, Garfein RS, Jackson RL, Crudu V, Rodrigues C, Victor TC, Catanzaro A, Rodwell TC. Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis. BMC Infect Dis. 2016 08 31; 16:458. PMID: 27576542; PMCID: PMC5006534.
    6. Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, Johnson RH, Kusne S, Lisse J, MacDonald JD, Meyerson SL, Raksin PB, Siever J, Stevens DA, Sunenshine R, Theodore N. 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis. Clin Infect Dis. 2016 Sep 15; 63(6):e112-46. PMID: 27470238.
      View in: PubMed
    7. Kambli P, Ajbani K, Nikam C, Sadani M, Shetty A, Udwadia Z, Georghiou SB, Rodwell TC, Catanzaro A, Rodrigues C. Corrigendum to "Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables" [Int. J. Mycobacteriol. 5(1) 2016 1-6]. Int J Mycobacteriol. 2016 09; 5(3):370-372. PMID: 27847030.
      View in: PubMed
    8. Gao L, Bai L, Liu J, Lu W, Wang X, Li X, Du J, Chen X, Zhang H, Xin H, Sui H, Li H, Su H, He J, Pan S, Peng H, Xu Z, Catanzaro A, Evans TG, Zhang Z, Ma Y, Li M, Feng B, Li Z, Guan L, Shen F, Wang Z, Zhu T, Yang S, Si H, Wang Y, Tan Y, Chen T, Chen C, Xia Y, Cheng S, Xu W, Jin Q. Annual risk of tuberculosis infection in rural China: a population-based prospective study. Eur Respir J. 2016 07; 48(1):168-78. PMID: 27230438.
      View in: PubMed
    9. Berrada ZL, Lin SY, Rodwell TC, Nguyen D, Schecter GF, Pham L, Janda JM, Elmaraachli W, Catanzaro A, Desmond E. Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex. Diagn Microbiol Infect Dis. 2016 Jun; 85(2):177-81. PMID: 27036978; PMCID: PMC4873381 [Available on 06/01/17].
    10. Seifert M, Georghiou SB, Catanzaro D, Rodrigues C, Crudu V, Victor TC, Garfein RS, Catanzaro A, Rodwell TC. MTBDRplus and MTBDRsl Assays: Absence of Wild-Type Probe Hybridization and Implications for Detection of Drug-Resistant Tuberculosis. J Clin Microbiol. 2016 Apr; 54(4):912-8. PMID: 26763971; PMCID: PMC4809938 [Available on 10/01/16].
    11. Kambli P, Ajbani K, Nikam C, Sadani M, Shetty A, Udwadia Z, Georghiou SB, Rodwell TC, Catanzaro A, Rodrigues C. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables. Int J Mycobacteriol. 2016 Mar; 5(1):1-6. PMID: 26927983.
      View in: PubMed
    12. Catanzaro A, Rodwell TC, Catanzaro DG, Garfein RS, Jackson RL, Seifert M, Georghiou SB, Trollip A, Groessl E, Hillery N, Crudu V, Victor TC, Rodrigues C, Lin GS, Valafar F, Desmond E, Eisenach K. Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis. PLoS One. 2015; 10(8):e0136861. PMID: 26322781; PMCID: PMC4556461.
    13. Torres JN, Paul LV, Rodwell TC, Victor TC, Amallraja AM, Elghraoui A, Goodmanson AP, Ramirez-Busby SM, Chawla A, Zadorozhny V, Streicher EM, Sirgel FA, Catanzaro D, Rodrigues C, Gler MT, Crudu V, Catanzaro A, Valafar F. Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates. Emerg Microbes Infect. 2015 Jul; 4(7):e42. PMID: 26251830; PMCID: PMC4522615.
    14. Colman RE, Schupp JM, Hicks ND, Smith DE, Buchhagen JL, Valafar F, Crudu V, Romancenco E, Noroc E, Jackson L, Catanzaro DG, Rodwell TC, Catanzaro A, Keim P, Engelthaler DM. Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing. PLoS One. 2015; 10(5):e0126626. PMID: 25970423; PMCID: PMC4430321.
    15. Avalos E, Catanzaro D, Catanzaro A, Ganiats T, Brodine S, Alcaraz J, Rodwell T. Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review. PLoS One. 2015; 10(3):e0120470. PMID: 25816236; PMCID: PMC4376704.
    16. Seifert M, Catanzaro D, Catanzaro A, Rodwell TC. Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review. PLoS One. 2015; 10(3):e0119628. PMID: 25799046; PMCID: PMC4370653.
    17. Gao L, Lu W, Bai L, Wang X, Xu J, Catanzaro A, Cárdenas V, Li X, Yang Y, Du J, Sui H, Xia Y, Li M, Feng B, Li Z, Xin H, Zhao R, Liu J, Pan S, Shen F, He J, Yang S, Si H, Wang Y, Xu Z, Tan Y, Chen T, Xu W, Peng H, Wang Z, Zhu T, Zhou F, Liu H, Zhao Y, Cheng S, Jin Q. Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis. 2015 Mar; 15(3):310-9. PMID: 25681063.
      View in: PubMed
    18. Kambli P, Ajbani K, Sadani M, Nikam C, Shetty A, Udwadia Z, Georghiou SB, Rodwell TC, Catanzaro A, Rodrigues C. Defining multidrug-resistant tuberculosis: correlating GenoType MTBDRplus assay results with minimum inhibitory concentrations. Diagn Microbiol Infect Dis. 2015 May; 82(1):49-53. PMID: 25749461; PMCID: PMC4414878.
    19. Kambli P, Ajbani K, Sadani M, Nikam C, Shetty A, Udwadia Z, Rodwell TC, Catanzaro A, Rodrigues C. Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay. Tuberculosis (Edinb). 2015 Mar; 95(2):137-41. PMID: 25522842; PMCID: PMC4361297.
    20. Hillery N, Groessl EJ, Trollip A, Catanzaro D, Jackson L, Rodwell TC, Garfein RS, Lin SY, Eisenach K, Ganiats TG, Park D, Valafar F, Rodrigues C, Crudu V, Victor TC, Catanzaro A. The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis. Trials. 2014 Nov 06; 15:434. PMID: 25377177; PMCID: PMC4232628.
    21. Ajbani K, Lin SY, Rodrigues C, Nguyen D, Arroyo F, Kaping J, Jackson L, Garfein RS, Catanzaro D, Eisenach K, Victor TC, Crudu V, Gler MT, Ismail N, Desmond E, Catanzaro A, Rodwell TC. Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries. Antimicrob Agents Chemother. 2015 Jan; 59(1):414-20. PMID: 25367911; PMCID: PMC4291380.
    22. Rodwell TC, Valafar F, Douglas J, Qian L, Garfein RS, Chawla A, Torres J, Zadorozhny V, Kim MS, Hoshide M, Catanzaro D, Jackson L, Lin G, Desmond E, Rodrigues C, Eisenach K, Victor TC, Ismail N, Crudu V, Gler MT, Catanzaro A. Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations. J Clin Microbiol. 2014 Mar; 52(3):781-9. PMID: 24353002; PMCID: PMC3957771.
    23. Lin SY, Rodwell TC, Victor TC, Rider EC, Pham L, Catanzaro A, Desmond EP. Pyrosequencing for rapid detection of extensively drug-resistant Mycobacterium tuberculosis in clinical isolates and clinical specimens. J Clin Microbiol. 2014 Feb; 52(2):475-82. PMID: 24478476; PMCID: PMC3911348.
    24. Bojorquez I, Barnes RF, Flood J, López-Gatell H, Garfein RS, Bäcker CE, Alpuche C, Vinetz JM, Catanzaro A, Kato-Maeda M, Rodwell TC. Multidrug-resistant tuberculosis among patients in Baja California, Mexico, and Hispanic patients in California. Am J Public Health. 2013 Jul; 103(7):1301-5. PMID: 23678924; PMCID: PMC3682598.
    25. Catanzaro A, Daley C. A summary of the Third Global Interferon-? Release Assay Symposium. Infect Control Hosp Epidemiol. 2013 Jun; 34(6):619-24. PMID: 23651894.
      View in: PubMed
    26. Daley CL, Reves RR, Beard MA, Boyle J, Clark RB, Beebe JL, Catanzaro A, Chen L, Desmond E, Dorman SE, Hudson TW, Lardizabal AA, Kapoor H, Marder DC, Miranda C, Narita M, Reichman L, Schwab D, Seaworth BJ, Terpeluk P, Thanassi W, Kawamura LM. A summary of meeting proceedings on addressing variability around the cut point in serial interferon-? release assay testing. Infect Control Hosp Epidemiol. 2013 Jun; 34(6):625-30. PMID: 23651895.
      View in: PubMed
    27. Bentley TG, Catanzaro A, Ganiats TG. Implications of the impact of prevalence on test thresholds and outcomes: lessons from tuberculosis. BMC Res Notes. 2012 Oct 10; 5:563. PMID: 23050607; PMCID: PMC3503683.
    28. Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, Rodwell TC. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PLoS One. 2012; 7(3):e33275. PMID: 22479378; PMCID: PMC3315572.
    29. Bercovitch RS, Catanzaro A, Schwartz BS, Pappagianis D, Watts DH, Ampel NM. Coccidioidomycosis during pregnancy: a review and recommendations for management. Clin Infect Dis. 2011 Aug; 53(4):363-8. PMID: 21810749.
      View in: PubMed
    30. Limper AH, Knox KS, Sarosi GA, Ampel NM, Bennett JE, Catanzaro A, Davies SF, Dismukes WE, Hage CA, Marr KA, Mody CH, Perfect JR, Stevens DA. An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011 Jan 01; 183(1):96-128. PMID: 21193785.
      View in: PubMed
    31. Jackson M, Harrity S, Hoffman H, Catanzaro A. A survey of health professions students for knowledge, attitudes, and confidence about tuberculosis, 2005. BMC Public Health. 2007 Aug 28; 7:219. PMID: 17725842; PMCID: PMC2034553.
    32. Catanzaro A, Cloud GA, Stevens DA, Levine BE, Williams PL, Johnson RH, Rendon A, Mirels LF, Lutz JE, Holloway M, Galgiani JN. Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis. Clin Infect Dis. 2007 Sep 01; 45(5):562-8. PMID: 17682989.
      View in: PubMed
    33. Stevens DA, Rendon A, Gaona-Flores V, Catanzaro A, Anstead GM, Pedicone L, Graybill JR. Posaconazole therapy for chronic refractory coccidioidomycosis. Chest. 2007 Sep; 132(3):952-8. PMID: 17573510.
      View in: PubMed
    34. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Winthrop K. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007 Feb 15; 175(4):367-416. PMID: 17277290.
      View in: PubMed
    35. Lam PK, Griffith DE, Aksamit TR, Ruoss SJ, Garay SM, Daley CL, Catanzaro A. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2006 Jun 01; 173(11):1283-9. PMID: 16514112.
      View in: PubMed
    36. Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Johnson RH, Stevens DA, Williams PL. Coccidioidomycosis. Clin Infect Dis. 2005 Nov 01; 41(9):1217-23. PMID: 16206093.
      View in: PubMed
    37. Catanzaro A. Coccidioidomycosis. Semin Respir Crit Care Med. 2004 Apr; 25(2):123-8. PMID: 16088456.
      View in: PubMed
    38. Lambert L, Rajbhandary S, Quails N, Budnick L, Catanzaro A, Cook S, Daniels-Cuevas L, Garber E, Reves R. Costs of implementing and maintaining a tuberculin skin test program in hospitals and health departments. Infect Control Hosp Epidemiol. 2003 Nov; 24(11):814-20. PMID: 14649768.
      View in: PubMed
    39. Hovell M, Blumberg E, Gil-Trejo L, Vera A, Kelley N, Sipan C, Hofstetter CR, Marshall S, Berg J, Friedman L, Catanzaro A, Moser K. Predictors of adherence to treatment for latent tuberculosis infection in high-risk Latino adolescents: a behavioral epidemiological analysis. Soc Sci Med. 2003 Apr; 56(8):1789-96. PMID: 12639595.
      View in: PubMed
    40. Catanzaro A. Diagnosis, differentiating colonization, infection, and disease. Clin Chest Med. 2002 Sep; 23(3):599-601, vi. PMID: 12370995.
      View in: PubMed
    41. Rao SP, Hayashi T, Catanzaro A. Identification of a chemotactic, MCP-1-like protein from Mycobacterium avium. FEMS Immunol Med Microbiol. 2002 Jun 03; 33(2):115-24. PMID: 12052566.
      View in: PubMed
    42. Perry S, Hovell MF, Blumberg E, Berg J, Vera A, Sipan C, Kelley N, Moser K, Catanzaro A, Friedman L. Urine testing to monitor adherence to TB preventive therapy. J Clin Epidemiol. 2002 Mar; 55(3):235-8. PMID: 11864793.
      View in: PubMed
    43. Catanzaro A, Perry S, Clarridge JE, Dunbar S, Goodnight-White S, LoBue PA, Peter C, Pfyffer GE, Sierra MF, Weber R, Woods G, Mathews G, Jonas V, Smith K, Della-Latta P. The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: results of a multicenter prospective trial. JAMA. 2000 Feb 02; 283(5):639-45. PMID: 10665704.
      View in: PubMed